Pfizer to supply Britain 2.5m courses of investigational COVID-19 treatments
Pfizer Inc has announced that it will provide an additional 2.5 million treatment courses of its investigational candidate Paxlovid to the United Kingdom. This is in addition to the 250,000...
Read moreDetails








